Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.6%

209 terminated/withdrawn out of 1262 trials

Success Rate

77.0%

-9.5% vs industry average

Late-Stage Pipeline

7%

94 trials in Phase 3/4

Results Transparency

42%

296 of 698 completed trials have results

Key Signals

187 recruiting296 with results144 terminated65 withdrawn

Enrollment Performance

Analytics

N/A
519(53.7%)
Phase 2
169(17.5%)
Phase 1
129(13.4%)
Early Phase 1
55(5.7%)
Phase 4
49(5.1%)
Phase 3
45(4.7%)
966Total
N/A(519)
Phase 2(169)
Phase 1(129)
Early Phase 1(55)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1262)

Showing 20 of 1262 trials
NCT05138601Not ApplicableActive Not Recruiting

Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II

Role: collaborator

NCT06439979Not ApplicableRecruiting

Rural Adult and Youth Sun Protection Study

Role: lead

NCT07404839Not ApplicableRecruiting

Scaling up Building Healthy Families

Role: lead

NCT03306992Phase 3Completed

Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study

Role: lead

NCT03627403Phase 2Terminated

Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors

Role: lead

NCT05613894Phase 1Suspended

Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer

Role: lead

NCT07136415Phase 4Recruiting

Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms

Role: collaborator

NCT07410689Not ApplicableNot Yet Recruiting

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

Role: lead

NCT05723055Phase 2Active Not Recruiting

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Role: lead

NCT06227026Phase 1Recruiting

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Role: lead

NCT06738355Not ApplicableCompleted

PREVENT Pilot HPV - Related Cancers Trial

Role: lead

NCT05168618Phase 2Recruiting

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Role: lead

NCT06967467Enrolling By Invitation

Allergy Delabeling in Antibiotic Stewardship - Evaluations

Role: collaborator

NCT04347759Not ApplicableCompleted

Symptom Care at Home-Heart Failure

Role: collaborator

NCT06501859Not ApplicableEnrolling By Invitation

Rehabilitation With the Shoulder Pacemaker

Role: lead

NCT05405387Phase 2Recruiting

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Role: lead

NCT06513182Not ApplicableCompleted

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?

Role: lead

NCT07217145Phase 3Active Not Recruiting

PREVENT HPV -Related Cancers Trial

Role: lead

NCT05535764Phase 1Recruiting

AlloHCT With PegINFa for Myelofibrosis

Role: lead

NCT07528352Phase 1Recruiting

External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL

Role: lead